Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022

Rhea-AI Summary

Voting Rights Update: As of July 31, 2022, Erytech Pharma reported a total of 31,018,553 shares in its capital. The gross voting rights stood at 32,521,126, while net voting rights were recorded at 32,518,626. This data is crucial as it provides insights into shareholder voting power and potential influence on company decisions. The figures reflect a stable share count with consistent voting rights, ensuring transparency in governance.

                Monthly information related to total number of voting rights and shares composing the share capital _July 31, 2022.

Article 223-16 of general regulation of French Autorité des Marchés Financiers
Lyon – France

---

Listing markets:
Euronext Paris from Euronext (Market segment C - ISIN Code: FR0011471135- Symbol: ERYP) &
Nasdaq Global Select Market in the United-States (Symbol : ERYP)
Website : www.erytech.com

Date	Total of shares composing the share capital	Total of brut (1) voting rights	Total of net (2) voting rights
December 31, 2021	31 018 553	32 518 339	32 515 839
January 31, 2022	31 018 553	32 518 339	32 515 839
February 28, 2022	31 018 553	32 518 547	32 516 047
March 31, 2022	31 018 553	32 518 547	32 516 047
April 30, 2022	31 018 553	32 518 547	32 516 047
May 31, 2022	31 018 553	32 518 547	32 516 047
June 30, 2022	31 018 553	32 520 107	32 517 607
July 31, 2022	31 018 553	32 521 126	32 518 626

⁽¹⁾   Gross voting rights number (or « theoretical » voting rights) is used as a basis for calculating the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.
⁽²⁾   Without treasury shares.

Attachment

• CP_Déclaration Droits de Vote 31 07 2022 vENG

FAQ

What are the total voting rights for ERPY as of July 31, 2022?

As of July 31, 2022, the total voting rights for ERPY were 32,521,126.

How many shares compose the share capital for ERPY?

Erytech Pharma's share capital comprises 31,018,553 shares.

What is the difference between gross and net voting rights for ERPY?

The gross voting rights for ERPY are 32,521,126, while the net voting rights are 32,518,626, indicating minimal treasury shares.